- Furman BL. Antithyroid Agents. 2016.
- Kadhim S, Musa A, Abed Al-Kareem Z, Ubaid M, Aziz N. The analysis of the protective feature of Nigella sativa in reducing Carbimazole toxicity including liver and kidney parameters on Albino male rats. Sci J Med Res. 2018;2(5):14-8.
- Skellern G, Knight B, Low C, Alexander W, McLarty D, Kalk W. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Br J Clin Pharmacol. 1980;9(2):137-43.
- Frenais R, Burgaud S, Horspool L. Pharmacokinetics of controlled‐release carbimazole tablets support once daily dosing in cats. J Vet Pharmacol Thers. 2008;31(3):213-9.
- Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-17.
- Kota SK, Meher LK, Kota SK, Jammula S, Modi KD. Carbimazole-induced cholestatic hepatitis in Graves’ disease. Indian J Endocrinol Metab. 2013;17(2):326.
- Jain K, Chakrapani M, Smitha K. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole. Ann Afr Med. 2010;9(2).
- NEKI N, Aloona S. Cholestatic Jaundice Induced by Sequential Carbimazole and Propylthiouracil Treatment for Thyrotoxicosis-A Case Report. Hong Kong Med J. 2013;9(5):377-80.
- Francis T, Francis N, Lazarus JH, Okosieme OE. Safety of antithyroid drugs in pregnancy: update and therapy implications. Expert Opinion on Drug Safety. 2020;19(5):565-76.
- Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 2004;87:44-53.
- Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013;57(9):1510-28.
- Niranjan A, Prakash D. Chemical constituents and biological activities of turmeric (Curcuma longa l.)-a review. J Food Sci Technol. 2008;45(2):109.
- Sudjarwo SA, Giftania Wardani Sudjarwo K. Protective effect of curcumin on lead acetate-induced testicular toxicity in Wistar rats. Res Pharm Sci. 2017;12(5):381.
- Liu H, Wang C, Qiao Z, Xu Y. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharm Biol. 2017;55(1):1144-8.
- Kheradpezhouh E, Panjehshahin M-R, Miri R, Javidnia K, Noorafshan A, Monabati A, et al. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. Eur J Pharmacol. 2010;628(1-3):274-81.
- Cano-Europa E, Blas-Valdivia V, Franco-Colin M, Gallardo-Casas CA, Ortiz-Butrón R. Methimazole-induced hypothyroidism causes cellular damage in the spleen, heart, liver, lung and kidney. Acta Histochemica. 2011;113(1):1-5.
- Li S, Tan H-Y, Wang N, Zhang Z-J, Lao L, Wong C-W, et al. The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci. 2015;16(11):26087-124.
- Zhu R, Wang Y, Zhang L, Guo Q. Oxidative stress and liver disease. Hepatol Res. 2012;42(8):741-9.
- Heidari R, Babaei H, Roshangar L, Eghbal MA. Effects of enzyme induction and/or glutathione depletion on methimazole-induced hepatotoxicity in mice and the protective role of N-acetylcysteine. Adv Pharm Bull. 2014;4(1):21.
- Heidari R, Babaei H, Eghbal M. Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes. Drug Chem Toxicol. 2013;36(4):403-11.
- Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease: Springer; 2007. p. 105-25.
- Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40-59.
- Vaiserman A, Koliada A, Zayachkivska A, Lushchak O. Curcumin: A therapeutic potential in ageing-related disorders. PharmaNutrition. 2020:100226.
24. Ulubay M, Alkan I, Yurt KK, Kaplan S. The protective effect of curcumin on the diabetic rat kidney: A stereological, electron microscopic and immunohistochemical study. Acta Histochemica. 2020;122(2):151486.
|